

Prognostic significance of X-сhromosome inactivation in female carriers of EDA mutations
https://doi.org/10.25557/2073-7998.2025.06.66-69
Abstract
Introduction. Ectodermal dysplasia (ED) represents a heterogeneous group of genetic disorders associated with impaired development of ectodermal structures. The most common form is X-linked hypohidrotic ectodermal dysplasia (XLHED), caused by mutations in the EDA gene, which encodes ectodysplasin A, a key protein involved in the development of ectodermal tissues. Due to the X-linked inheritance pattern, males are more frequently affected; however, female carriers may also exhibit clinical manifestations. The phenotypic variability in females has traditionally been attributed to skewed X-chromosome inactivation (XCI), though this hypothesis remains controversial.
Objective: The aim of this study was to analyze XCI patterns in female carriers of EDA mutations and assess their correlation with the severity of clinical manifestations.
Methods. The study was conducted on 47 female patients using methylation-sensitive PCR and analysis of repeats in the AR gene.
Results. The obtained data did not reveal a statistically significant correlation between the degree of XCI and the severity of HED symptoms (p = 0.277).
Conclusion. This study confirms that the analysis of XCI in blood is not a reliable predictor of disease severity in females with X-linked HED and, therefore, should not be recommended for diagnostic purposes or reclassification of variants of uncertain significance in the EDA gene.
About the Authors
V. A. KovalskaiaRussian Federation
1, Moskvorechye st, Moscow, 115522
T. B. Cherevatova
Russian Federation
1, Moskvorechye st, Moscow, 115522
E. V. Zinina
Russian Federation
1, Moskvorechye st, Moscow, 115522
A. A. Stepanova
Russian Federation
1, Moskvorechye st, Moscow, 115522
O. A. Schagina
Russian Federation
1, Moskvorechye st, Moscow, 115522
A. V. Polyakov
Russian Federation
1, Moskvorechye st, Moscow, 115522
O. P. Ryzhkova
Russian Federation
1, Moskvorechye st, Moscow, 115522
References
1. Itin P. H., Fistarol S. K. Ectodermal dysplasias. American Journal of Medical Genetics. 2004; 131C(1), 45–51. doi:10.1002/ajmg.c.30033
2. Wright J.T., Fete M., Schneider H., et. al. Ectodermal dysplasias: Classification and organization by phenotype, genotype and molecular pathway. Am J Med Genet A. 2019;179(3):442-447. doi: 10.1002/ajmg.a.61045.
3. Herlin L.K., Schmidt S.A.J., Hermann X.B., et. al. Prevalence and Patient Characteristics of Ectodermal Dysplasias in Denmark. JAMA Dermatol. 2024;160(5):502-510. doi: 10.1001/jamadermatol.2024.0036.
4. Butcher C., Abbott B.M., Grange D., et. al. Prevalence rates for ectodermal dysplasia syndromes. Am J Med Genet A. 2024;194(12):e63832. doi: 10.1002/ajmg.a.63832.
5. Bayés M., Hartung A., Ezer S., et. al. The anhidrotic ectodermal dysplasia gene (EDA) undergoes alternative splicing and encodes ectodysplasin-A with deletion mutations in collagenous repeats. Hum. Mol. Genet. 1998;7(11):1661-1669. DOI 10.1093/hmg/7.11.1661.
6. Mikkola M., Thesleff I. Ectodysplasin signaling in development. Cytokine Growth Factor Rev. 2003;14(3-4):211-224. DOI 10.1016/s1359-6101(03)00020-0
7. Puck J.M., Willard H.F. X inactivation in females with X-linked disease. N Engl J Med. 1998;338(5):325-8. doi: 10.1056/NEJM199801293380611.
8. Migeon B.R. X-linked diseases: susceptible females. Genet Med. 2020; 22: 1156–1174, https://doi.org/10.1038/s41436-020-0779-4
9. Martínez-Romero M.C., Ballesta-Martínez M.J., López-González V., et. al.; GIEDE (Spanish multidisciplinary research group for ectodermal dysplasia). EDA, EDAR, EDARADD and WNT10A allelic variants in patients with ectodermal derivative impairment in the Spanish population. Orphanet J Rare Dis. 2019;14(1):281. doi: 10.1186/s13023-019-1251-x.
10. Körber L., Schneider H., Fleischer N. et. al. No evidence for preferential X-chromosome inactivation as the main cause of divergent phenotypes in sisters with X-linked hypohidrotic ectodermal dysplasia. Orphanet J Rare Dis. 2021; 16: 98. https://doi.org/10.1186/s13023-021-01735-2
Review
For citations:
Kovalskaia V.A., Cherevatova T.B., Zinina E.V., Stepanova A.A., Schagina O.A., Polyakov A.V., Ryzhkova O.P. Prognostic significance of X-сhromosome inactivation in female carriers of EDA mutations. Medical Genetics. 2025;24(6):66-69. (In Russ.) https://doi.org/10.25557/2073-7998.2025.06.66-69